13F filer · CIK 1032165
FRAZIER MANAGEMENT LLC
SEATTLE, WA · filing since Q4 2015 · last filing Nov 14, 2022
Reported value
$1.1M
$-871.0K vs prior
Positions
1
New / sold out
0 / 1
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $2.1M
Top-10 weight
100.0%
Biggest buys vs Q1 2022
No new or increased positions this quarter.
Biggest sells vs Q1 2022
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SIERRA ONCOLOGY INC | -34,338 | -62.8% | $-1.9M |
| Sold out | ALLENA PHARMACEUTICALS | -1,019,288 | -100.0% | $-236.0K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2022
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SIERRA ONCOLOGY INCCOM NEW | 20,316 | $1.1M | 100.00% |